Article
The MALAT1-EZH2 axis regulates PRC2 activity and promotes the mesenchymal phenotype in pediatric atypical teratoid/rhabdoid tumors.
Journal of neuro-oncology - 31 Mar 2026
Gurbuz Melisa, Tekin Cagla, Ercelik Melis, Koc Sevin Avsar, Kockar Feray, Eser Pınar, Taskapilioglu Mevlut Ozgur, Tezcan Gulcin, Erbaykent Burcu, Bekar Ahmet, Kocaeli Hasan, Ozsen Mine, Karabaglı Pınar, Karabaglı Hakan, Bayrak Buşra Yaprak, Etus Volkan, Tunca Berrin
Abstract excerpt
BACKGROUND: Atypical teratoid/rhabdoid tumors (AT/RT) are aggressive pediatric CNS malignancies characterized by SMARCB1 loss, which leads to the dysregulated expression of Enhancer of Zeste Homolog 2 (EZH2), a key catalytic component of the Polycomb Repressive Complex 2 (PRC2). This dysregulation results in aberrant trimethylation of histone H3 at lysine 27 (H3K27me3), driving tumor progression. While EZH2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
